Demo science and technology news and video feed


NewsKnowledge.com News Feed


 Biotechnology News
 

  Arrowhead Conferences' Drug Delivery 2007 to Take Place April 9th-11th 2007 in San Francisco  
Drug Delivery 2007 has been organized to provide a critical examination of the drug delivery industry as well as insight from key industry leaders concerning cutting edge drug delivery technology, structuring mutually beneficial deals and the drug delivery industry's impact on the field of biote...  
02/19/2007 02:28pm - PR Web: Biotechnology  
  Biotech Week in Review: Onyx Is Star of the Week  
Centient Biotech Investor submits: A very minor advance was the best that biotech could do last week. The Centient Biotech 200TM rose just 4 points, which equates to a small one-tenth of one percentage point, ending at 4054. That is not much in the way of change. But even if last week was n...  
02/19/2007 02:19pm - SeekingAlpha Biotech Stocks  
  Pro-Pharmaceuticals seeks early market clearance to boost biz  
With available cash just months away from running dry, Newton-based biotechnology firm Pro-Pharmaceuticals Inc. this week submitted an early application to the U.S. Food and Drug Administration to gain market clearance for the use of its lead cancer drug, Davanat, in combination with an approved...  
02/19/2007 11:46am - BizJournals.com: Biotechnology  
  What became of last year's grants?  
Art students don't exactly come to mind as being probable candidates for biotechnology internships, but Salem College wanted to break that mold.  
02/19/2007 11:46am - BizJournals.com: Biotechnology  
  Elixir Pharmaceuticals and Siena Biotech S.p.A. enter Agreement to Evaluate SIRT1 Inhibitors in Huntington's Disease  
Elixir Pharmaceuticals, Inc. and Siena Biotech S.p.A. announced that the two companies have entered into an agreement to collaborate on the optimization, validation and evaluation of Elixir's SIRT1 ...  
02/19/2007 05:22am - Bionity.com  
  Complaint Properly Shows That Defendants' Statements Were Misleading, Investors Argue  
PHILADELPHIA - A complaint filed by investors of biotechnology company Discovery Laboratories Inc. should not be dismissed because the investors have properly shown that the defendants issued a series of misrepresentations in violation of federal securities laws and acted with scienter, the inve...  
02/18/2007 09:12am - LexisNexis Mealey Emerging Securities Litigation Legal News  
  Amazon Biotech, Inc.: Harbinger Research Issues Research Brief for Amazon Biotech Inc. With a Speculative Buy Rating and Price Target of $0.25  
NEW YORK, NY (MARKET WIRE) Harbinger Research LLC, www.harbingerresearch.com, an independent research firm, issued a Research Brief today for Amazon Biotech, Inc. (OTCBB: AMZB), a development stage pharmaceutical/biotech company that is developing an all natural drug (AMZ 0026) for the treatmen...  
02/17/2007 06:09am - MarketWire: Pharmaceuticals and Biotech  
  Amazon Biotech, Inc: Amazon Biotech, Inc. Announces Issuance of Patent for a Unique Formulation and Method of Treating HIV Infection  
NEW YORK, NY (MARKET WIRE) Amazon Biotech, Inc. (OTCBB: AMZB) (FRANKFURT: B2D) announced that it has been issued a patent from the United States Patent and Trademark Office, patent # 7,160,561 for "a herbal composition and method of treating HIV infection.  
02/17/2007 04:03am - MarketWire: Pharmaceuticals and Biotech  
  GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin  
Martinsried/Munich (Germany), Waltham, Mass. and Princeton, N.J., February 16, 2007 — GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index; NASDAQ: GPCB) today announced that the Company has co... [WebWire - Friday, February 16, 2007]  
02/16/2007 09:33pm - WebWire(R) - Health Care/Hospitals  
  MediGene Obtains European Patent on EndoTAGTM-1  
Martinsried/Munich, February 16, 2007. Today the German-American biotech company MediGene AG (Frankfurt, Prime Standard: MDG) announced that the European patent office has granted a patent covering th... [WebWire - Friday, February 16, 2007]  
02/16/2007 09:33pm - WebWire(R) - Health Care/Hospitals  
  Q & A :: RE: stevia plants available@1.10 per plant  
Author: kirti s Posted: Fri Feb 16, 2007 1:46 pm (GMT 0) Topic Replies: 2 Hello Sir Sir the below concerned has a buy bac scheme for stevia. Ayurmeda Biotech Pvt ltd Vinod Haritwal 31, New silver home 15 New Kantwadi road Bandra West Mumbai MH 912226421551 ...  
02/16/2007 08:48pm - AgricultureInformation.com  
  GPC Biotech seeks FDA OK for prostate cancer drug  
GPC Biotech AG, a German firm with offices in Waltham, has submitted an application to the U.S. Food and Drug Administration to gain approval for its drug satraplatin as a treatment for prostate cancer, officials report.  
02/16/2007 11:15pm - BizJournals.com: Biotechnology  
  TaiGen Appoints Dr. Luke Lin VP of Clinical Research & Development  
TAIPEI, Taiwan, Feb. 14 /Xinhua-PRNewswire-FirstCall/ -- TaiGen Biotechnology Inc., a private Taiwan based biopharmaceutical company developing novel therapeutics to treat infectious diseases, cancer and diabetic complications, today announced the appointment of Dr. Luke Lin as Vice President of...  
02/16/2007 08:43pm - Drug Newswire  
  Cougar Biotechnology Names Richard B. Phillips, Ph.D. Vice President of Regulatory Affairs and Quality Assurance  
Los Angeles, CA, February 14, 2007 /PRNewswire-FirstCall/ -- Cougar Biotechnology, Inc. (BULLETIN BOARD: CGRB) , a biotechnology company focused on acquiring and developing oncology drug candidates, today announced the appointment of Richard B. Phillips, Ph.D., to the position of Vice President ...  
02/16/2007 07:18pm - Drug Newswire  
  Q & A :: RE: Safed Masuli roots for Planting  
Author: kirti s Posted: Fri Feb 16, 2007 1:07 pm (GMT 0) Topic Replies: 3 Dear Sir U may please contact the below concerned for the required information Shah And Patil Farms Sellers of aloevera plants, leaves and gel, amla fresh and powder and safed musli roots. Addres...  
02/16/2007 07:15pm - AgricultureInformation.com  
  First Patients Undergo Surgery in Northwest Biotherapeutics' Phase II Brain Cancer Trial  
Personalized Cancer Immunotherapy for Glioblastoma Multiforme BOTHELL, Wash., Feb. 13 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (BULLETIN BOARD: NWBT.OB) , a biotechnology company focused on cancer immunotherapy, today announced that the first two patients in its pivotal ...  
02/16/2007 01:36pm - Drug Newswire  
  BioVeris Launches New Products for Life Sciences  
Cytokine Biomarkers and Antibody Panels Introduced For Sale GAITHERSBURG, Md., Feb. 13 /PRNewswire-FirstCall/ -- BioVeris Corporation (NASDAQ:BIOV) announced today that it has introduced for sale eight new products for use in life science research. These new products are focused on meeti...  
02/16/2007 01:36pm - Drug Newswire  
  EFFECTS AND VALUE OF VERIFIABLE INFORMATION IN A CONTROVERSIAL MARKET: EVIDENCE FROM LAB AUCTIONS OF GENETICALLY MODIFIED FOOD  
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1465-7295.2007.00017.x Abstract: Food products containing genetically modified (GM) ingredients have entered the market over the past decade. The biotech industry and environmental groups have disseminated conflicting private information about G...  
02/16/2007 10:21am - Environmental Valuation Cost Benefit News  

News provided by newsknowledge.com  



Design & CMS by insign - simply e-business


HOMEPRODUCTSHeadline News FeedsTopic FeedsSample Topic Feed
SEARCH CONTACT US SITEMAP MEMBERS LOGIN